These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30987721)

  • 41. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells.
    Espi M; Koppe L; Fouque D; Thaunat O
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32384617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
    Olivier V; Dunyach-Remy C; Corbeau P; Cristol JP; Sutra T; Burtey S; Lavigne JP; Moranne O
    BMC Nephrol; 2020 Apr; 21(1):141. PubMed ID: 32316931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E).
    Zhao YY; Cheng XL; Wei F; Bai X; Tan XJ; Lin RC; Mei Q
    J Proteome Res; 2013 Feb; 12(2):692-703. PubMed ID: 23227912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating
    Chang JF; Hsieh CY; Liou JC; Lu KC; Zheng CM; Wu MS; Chang SW; Wang TM; Wu CC
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.
    Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J
    J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease.
    Melekoglu E; Cetinkaya MA; Kepekci-Tekkeli SE; Kul O; Samur G
    PLoS One; 2021; 16(10):e0258145. PubMed ID: 34614017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.
    Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L;
    J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uremic toxin development in living kidney donors: a longitudinal study.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM
    Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein-bound uremic toxins: new insight from clinical studies.
    Liabeuf S; Drüeke TB; Massy ZA
    Toxins (Basel); 2011 Jul; 3(7):911-9. PubMed ID: 22069747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association of uremic toxins and inflammation in hemodialysis patients.
    Hsu HJ; Yen CH; Wu IW; Hsu KH; Chen CK; Sun CY; Chou CC; Chen CY; Tsai CJ; Wu MS; Lee CC
    PLoS One; 2014; 9(7):e102691. PubMed ID: 25051062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.
    Lin CJ; Chen HH; Pan CF; Chuang CK; Wang TJ; Sun FJ; Wu CJ
    J Clin Lab Anal; 2011; 25(3):191-7. PubMed ID: 21567467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson's disease.
    Sankowski B; Księżarczyk K; Raćkowska E; Szlufik S; Koziorowski D; Giebułtowicz J
    Clin Chim Acta; 2020 Feb; 501():165-173. PubMed ID: 31726035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uremic toxicity and sclerostin in chronic kidney disease patients.
    Desjardins L; Liabeuf S; Oliveira RB; Louvet L; Kamel S; Lemke HD; Vanholder R; Choukroun G; Massy ZA;
    Nephrol Ther; 2014 Nov; 10(6):463-70. PubMed ID: 25070604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes.
    Deltombe O; Glorieux G; Marzouki S; Masereeuw R; Schneditz D; Eloot S
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31266243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uremic Toxins and Vascular Dysfunction.
    Six I; Flissi N; Lenglet G; Louvet L; Kamel S; Gallet M; Massy ZA; Liabeuf S
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32570781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.